Related Experiment Video

Updated: Aug 16, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Cardiac involvement in sarcoidosis

Jane C Deng1, Robert P Baughman, Joseph P Lynch

  • 1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0360, USA.

Seminars in Respiratory and Critical Care Medicine
|August 10, 2005
PubMed

Insights

Cardiac sarcoidosis diagnosis is difficult, often requiring treatment without definitive proof. Early recognition and aggressive therapy, including corticosteroids and device implantation, are crucial for managing this life-threatening condition.

Area of Science:

  • Cardiology
  • Immunology
  • Pathology

Background:

  • Cardiac sarcoidosis presents a diagnostic challenge, with varied clinical manifestations from benign findings to fatal outcomes.
  • Histologic confirmation of myocardial sarcoidosis is often difficult, complicating management decisions.

Purpose of the Study:

  • To review the clinical features, diagnostic approaches, treatment strategies, and prognosis of cardiac sarcoidosis.
  • To highlight the challenges in diagnosing and managing cardiac sarcoidosis.

Main Methods:

  • Review of existing literature on cardiac sarcoidosis.
  • Discussion of diagnostic tools including thallium scintigraphy, echocardiography, and other radionuclide techniques.
  • Evaluation of treatment options such as corticosteroids, immunosuppressants, and device implantation.

Main Results:

  • Definitive diagnosis can be challenging, necessitating treatment based on clinical suspicion.
  • Thallium-201 scintigraphy is a key diagnostic tool, with echocardiography offering complementary information.
  • Aggressive, long-term treatment with corticosteroids or immunosuppressants is often required.
  • Automatic cardioverter-defibrillators may be necessary for recurrent tachyarrhythmias.

Conclusions:

  • Prompt diagnosis and aggressive treatment are vital for managing potentially fatal cardiac sarcoidosis.
  • Optimal diagnostic strategies and management protocols require further clarification.
  • Clinicians face significant obstacles in recognizing and effectively managing cardiac sarcoidosis.

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...